Back

Panel discussion.

30 August 2021 (15:25 - 15:30)
Organised by:
Congress Presentation Part of: Anticoagulation in Transcatheter Aortic Valve Implantation in Patients with Atrial Fibrillation: Results from ENVISAGE-TAVI AF trial. Atrial Fibrillation (AF) Open Access ESC Congress 2021 - The Digital Experience

3 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Doctor S. Saito (Kamakura, JP)
Presentation thumbnail
Edoxaban in patients with AF following TAVI: ENVISAGE-TAVI AF trial results.
Professor N. van Mieghem (Rotterdam, NL)
Presentation thumbnail
New developments in NOACs and TAVI: How do we apply them in clinical practice?
Professor D. Capodanno (Catania, IT)

Access the full session

Session thumbnail
Anticoagulation in Transcatheter Aortic Valve Implantation in Patients with Atrial Fibrillation: Results from ENVISAGE-TAVI AF trial.
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

30 August 2021 15:25 CET
You may be interested in
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation